The clinical content of preconception care: infectious diseases in preconception care

• Published in: American journal of obstetrics and gynecology 2008-12, Vol.199 (6), p.S296-S309
• Main Authors: Coonrod, Dean V., MD, MPH, Jack, Brian W., MD, Stubblefield, Phillip G., MD, Hollier, Lisa M., MD, MPH, Boggess, Kim A., MD, Cefalo, Robert, MD, PhD, Cox, Shanna N., MSPH, Dunlop, Anne L., MD, MPH, Hunter, Kam D., MD, PhD, Prasad, Mona R., DO, MPH, Lu, Michael C., MD, MS, MPH, Conry, Jeanne A., MD, PhD, Gibbs, Ronald S., MD, Hogan, Vijaya K., DrPH
• Format: Article
• Language: English
• Subjects: Bacterial Infections - prevention & control; Female; Humans; infectious disease; Obstetrics and Gynecology; Parasitic Diseases - prevention & control; preconception; Preconception Care; Pregnancy; Pregnancy Complications, Infectious - prevention & control; Prenatal Care; screening; Virus Diseases - prevention & control
• ISSN: 0002-9378; 1097-6868
• DOI: 10.1016/j.ajog.2008.08.062

A number of infectious diseases should be considered for inclusion as part of clinical preconception care. Those infections strongly recommended for health promotion messages and risk assessment or for the initiation of interventions include Chlamydia infection, syphilis, and HIV. For selected populations, the inclusion of interventions for tuberculosis, gonorrheal infection, and herpes simplex virus are recommended. No clear evidence exists for the specific inclusion in preconception care of hepatitis C, toxoplasmosis, cytomegalovirus, listeriosis, malaria, periodontal disease, and bacterial vaginosis (in those with a previous preterm birth). Some infections that have important consequences during pregnancy, such as bacterial vaginosis (in those with no history of preterm birth), asymptomatic bacteriuria, parvovirus, and group B streptococcus infection, most likely would not be improved through intervention in the preconception time frame.